Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jul;14(7):e12381.
doi: 10.1002/clt2.12381.

Dupilumab induces a significant decrease of food specific immunoglobulin E levels in pediatric atopic dermatitis patients

Lisa P van der Rijst  1   2 , Michelle S Hilbrands  2 , Nicolaas P A Zuithoff  3 , Marjolein S de Bruin-Weller  2 , André C Knulst  2 , Thuy-My Le  2 , Marlies de Graaf  1   2
Affiliations

Dupilumab induces a significant decrease of food specific immunoglobulin E levels in pediatric atopic dermatitis patients

Lisa P van der Rijst et al. Clin Transl Allergy. 2024 Jul.
No abstract available

Keywords: atopic dermatitis; children; dupilumab; food allergy; pediatric; specific immunoglobulin E.

PubMed Disclaimer

Conflict of interest statement

Lisa P. van der Rijst has been a speaker for AbbVie and Novartis; Michelle S. Hilbrands has nothing to disclose; Nicolaas P. A. Zuithoff has nothing to disclose; Marjolein S. de Bruin‐Weller has been a consultant, advisory board member, and/or speaker for AbbVie, Almirall, Amgen, Aslan, Eli Lilly, Galderma, Janssen, Leo Pharma, Pfizer, Regeneron Pharmaceuticals, and Sanofi; André C. Knulst has been a consultant, advisory board member, and/or speaker for ALK, Thermofisher, Nutricia/Danone, EUROIIMUN, DBV, and Novartis; Thuy‐My Le has been an advisory board member or speaker for Thermo Fisher Scientific, Novartis and Abbvie; Marlies de Graaf has been a consultant, advisor and/or speaker for AbbVie, Almirall, Eli Lilly, Janssen, Leo Pharma, Novartis, Pfizer, Regeneron Pharmaceuticals, and Sanofi.

Figures

FIGURE 1
FIGURE 1
Estimated percentage decrease of median sIgE levels during 1 year of dupilumab treatment in pediatric patients with moderate to severe AD for peanut, hazelnut, cashew nut, almond, walnut, pistachio, hen's egg, cow's milk, kiwi, and apple. Error bars indicate the 95% confidence interval. AD, atopic dermatitis; sIgE, specific immunoglobulin E.
See this image and copyright information in PMC

References

    1. Shaker MS, Schwartz J, Ferguson M. An update on the impact of food allergy on anxiety and quality of life. Curr Opin Pediatr. 2017;29(4):497‐502. 10.1097/mop.0000000000000509 - DOI - PubMed
    1. Achten R, Van der Rijst L, Piena M, et al. Economic and humanistic burden in paediatric patients with atopic dermatitis. Acta Derm Venereol. 2023;103:adv00881. 10.2340/actadv.v103.4842 - DOI - PMC - PubMed
    1. Papapostolou N, Xepapadaki P, Gregoriou S, Makris M. Atopic dermatitis and food allergy: a complex interplay what we know and what we would like to learn. J Clin Med. 2022;11(14):4232. 10.3390/jcm11144232 - DOI - PMC - PubMed
    1. Brough HA, Nadeau KC, Sindher SB, et al. Epicutaneous sensitization in the development of food allergy: what is the evidence and how can this be prevented? Allergy. 2020;75(9):2185‐2205. 10.1111/all.14304 - DOI - PMC - PubMed
    1. Spekhorst LS, van der Rijst LP, de Graaf M, et al. Dupilumab has a profound effect on specific‐IgE levels of several food allergens in atopic dermatitis patients. Allergy. 2022;78(3):875‐878. 10.1111/all.15591 - DOI - PubMed

LinkOut - more resources